[Malignant lymphoma associated with angioedema]. 1999

A Viczián, and P Szemere, and J Barcsák, and I Préda
Haynal Imre Egészségtudományi Egyetem, Budapest.

The incidence of malignant lymphoma cases in constantly growing. Therefore it is worth-while to consider its presence even in cases where the symptoms do not give a clear indication of the disease. Two cases with angiooema being rare and not carachteristic signs for malignant lymphoma are reported. The authors discuss the supposed paraneoplastic patomechanism in malignant lymphoma, i.e. the possible role of C' 1 inhibition. In the view at the cases discussed the authors propose to consider the possible diagnosis of malignant lymphoma if unexplained angiooedema is present.

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000799 Angioedema Swelling involving the deep DERMIS, subcutaneous, or submucosal tissues, representing localized EDEMA. Angioedema often occurs in the face, lips, tongue, and larynx. Quincke's Edema,Urticaria, Giant,Angioneurotic Edema,Angioedemas,Angioneurotic Edemas,Edema, Angioneurotic,Edema, Quincke's,Edemas, Angioneurotic,Giant Urticaria,Giant Urticarias,Quincke Edema,Quinckes Edema,Urticarias, Giant
D018046 Protein C Inhibitor A member of the serpin family of proteins that is found in plasma and urine. It is dependent on heparin and is able to inhibit activated PROTEIN C; THROMBIN; KALLIKREIN; and other SERINE ENDOPEPTIDASES. PAI-3,Plasminogen Activator Inhibitor 3,Activated Protein C Inhibitor,Plasminogen Activator Inhibitor, Type 3,Protein C Inhibitor, Activated,Serpin A5,Type 3 Plasminogen Activator Inhibitor

Related Publications

A Viczián, and P Szemere, and J Barcsák, and I Préda
June 1960, Rocky Mountain medical journal,
A Viczián, and P Szemere, and J Barcsák, and I Préda
January 2010, Internal medicine (Tokyo, Japan),
A Viczián, and P Szemere, and J Barcsák, and I Préda
June 1994, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
A Viczián, and P Szemere, and J Barcsák, and I Préda
May 1973, Rinsho shinkeigaku = Clinical neurology,
A Viczián, and P Szemere, and J Barcsák, and I Préda
May 1970, Archives of neurology,
A Viczián, and P Szemere, and J Barcsák, and I Préda
January 1978, Medical and pediatric oncology,
A Viczián, and P Szemere, and J Barcsák, and I Préda
August 1991, Deutsche medizinische Wochenschrift (1946),
A Viczián, and P Szemere, and J Barcsák, and I Préda
April 1990, [Rinsho ketsueki] The Japanese journal of clinical hematology,
A Viczián, and P Szemere, and J Barcsák, and I Préda
January 1959, Transactions of the American Ophthalmological Society,
A Viczián, and P Szemere, and J Barcsák, and I Préda
January 1967, Journal of neuropathology and experimental neurology,
Copied contents to your clipboard!